We perform simultaneous profiling of primary tumors and multiple metastatic sites in animal models to identify systemic versus niche-specific resistance across diverse organ environments.
Creative Biolabs provides a dual-layer approach to understanding metastatic biology. We deliver high-throughput transcriptomic profiling alongside sub-cellular spatial orientation, allowing researchers to see not only "what" genes are expressed but exactly "where" they are localized within the tissue architecture. By partnering with us, clients gain the ability to map the interaction between tumor cells and specialized stroma, identify metabolic shifts in the metastatic niche, and visualize immune exclusion zones. This provides a definitive biological roadmap to identify new research targets and optimize lead candidate selection in early-stage development.
The metastatic ecosystem is a highly organized fortress. Recent research emphasizes that metastasis is an organ-dictated process involving profound stromal remodeling and immune exclusion. By mapping these "neighborhoods" with sub-cellular precision, we move beyond simple genomic sequencing to understand the functional architecture of resistance. Creative Biolabs integrates the latest biological benchmarks to provide a reference map of the metastatic journey across multiple anatomic sites for research use.
Fig.1 Profiling of MBC biopsies using four spatial expression methods. 1
We perform simultaneous profiling of primary tumors and multiple metastatic sites in animal models to identify systemic versus niche-specific resistance across diverse organ environments.
Our team develops precision-engineered probe sets optimized for your specific research targets, ensuring the most relevant pathways and biomarkers are captured with high sensitivity.
We utilize specialized processing for core biopsies and FFPE blocks through proprietary single-nucleus isolation protocols, ensuring high-quality data from even the most difficult-to-dissociate research tissues.
We offer laboratory-to-pilot scale capabilities for longitudinal studies, maintaining rigorous data quality and consistency across large research cohorts to support robust statistical discovery and validation.
Creative Biolabs stands as a global leader in metastatic biology, leveraging long-standing specialized experience to help researchers navigate the complexities of tumor progression and niche colonization.
We possess a unique ability to process difficult research samples that others cannot, including small-volume core biopsies and highly calcified tissues with superior molecular preservation.
Our team selects the optimal spatial platform for your specific biological question, ensuring that every project utilizes the most effective tools for discovery and validation.
We apply high-resolution mapping and stringent quality controls to ensure that questions regarding metabolic reprogramming or immune exclusion are answered with absolute statistical rigor.
To experience the Creative Biolabs advantage and collaborate with our specialists to define a project scope that resolves your most pressing research hurdles - Get a Quote Today.
While mIHC looks at protein levels, our spatial mapping provides transcriptomic depth with sub-cellular resolution, allowing for the discovery of novel pathways that protein stains might miss.
Yes. Our single-nucleus protocols are specifically designed to extract high-quality transcriptomic data from archived frozen research samples where cell viability is no longer maintained.
This specialized service enables high-efficiency isolation and multi-omic characterization of circulating tumor cells in experimental models to clarify the complex liquid phase of metastatic dissemination.
Learn More →This analytical solution integrates genomic, transcriptomic, and spatial datasets to develop robust statistical risk models for predicting metastatic recurrence patterns within early-stage oncology discovery research.
Learn More →Creative Biolabs offers a sophisticated single-cell & spatial mapping service designed to resolve the biological complexity of the metastatic ecosystem. By combining discovery-scale transcriptomics with high-resolution spatial context, we empower our partners to identify targets and validate mechanisms in oncology research.
For information regarding our technical capabilities or to discuss your specific research project requirements - Get Started Today.
Reference